Bio Imaging

Published by: RI Technologies

Published: May. 1, 2008 - 370 Pages

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Introduction

Bioimaging

Medical Imaging

Molecular Imaging

Radiography

X-Rays

Gamma Rays

Computational Genomics

Dynamic Imaging

Biomarker

Radiopharmacology

Imaging Modalities

Magnetic Resonance Imaging

Optical Imaging

Diffuse Optical Imaging

Tomography

Modern Tomography

History of Methods and Technologies in Bioimaging

Electron Microscope

X-Rays

Radiology and Radiography

Fluoroscopy

Functional Magnetic Resonance Imaging (fMRI)

Computational Genomics

Computed Tomography

Imaging Atom Probe

Corneal Topography

High Intensity Focused Ultrasound

Brain Machine Interface

Magnetic Resonance Imaging

Medical Ultrasonography

Neuroimaging

Optical Coherence Tomography

Optoacoustic Imaging

Positron Emission Tomography

Single-Photon Emission Computed Tomography (SPECT)

Transmission Electron Microscopy

Drug Discovery with Bioimaging

Bioimaging Agents

Segmentation of Bioimaging

Exhibit 1: Segmentation of Global Bioimaging Market by Type (Medical and Molecular), by Application (Diagnostic and Research and Development) and Modalities (Ultrasound, CT, MRI, PET, SPECT and Other)

II. Global Market Analysis

Exhibit 2: Bioimaging (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Market Analysis by Geographic Region

Analysis by Type

Medical

Exhibit 3: Medical Bioimaging (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 4: Medical Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Molecular

Exhibit 5: Molecular Bioimaging (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 6: Molecular Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Analysis by Application

Diagnostic

Exhibit 7: Bioimaging in Diagnostics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 8: Bioimaging in Diagnostics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Research and Development

Exhibit 9: Bioimaging in Research and Development (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 10: Bioimaging in Research and Development (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Analysis by Modalities

Ultrasound

Exhibit 11: Bioimaging by Ultrasound (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 12: Bioimaging by Ultrasound (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

CT

Exhibit 13: Bioimaging by CT (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 14: Bioimaging by CT (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

MRI

Exhibit 15: Bioimaging by MRI (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 16: Bioimaging by MRI (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

PET

Exhibit 17: Bioimaging by PET (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 18: Bioimaging by PET (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

SPECT

Exhibit 19: Bioimaging by SPECT (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 20: Bioimaging by SPECT (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Other

Exhibit 21: Bioimaging by Other (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Million (Graphical Representation Included)

Exhibit 22: Bioimaging by Other (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (Graphical Representation Included)

Exhibit 23: List of Major Global Companies

III. Regional Market Analysis

North America

Exhibit 24: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Analysis by Type

Medical

Exhibit 25: Medical Bioimaging (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 26: Medical Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Molecular

Exhibit 27: Molecular Bioimaging (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 28: Molecular Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Analysis by Application

Diagnostic

Exhibit 29: Bioimaging in Diagnostics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 30: Bioimaging in Diagnostics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Research and Development

Exhibit 31: Bioimaging in Research and Development (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 32: Bioimaging in Research and Development (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Analysis by Modalities

Ultrasound

Exhibit 33: Bioimaging by Ultrasound (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 34: Bioimaging by Ultrasound (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

CT

Exhibit 35: Bioimaging by CT (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 36: Bioimaging by CT (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

MRI

Exhibit 37: Bioimaging by MRI (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 38: Bioimaging by MRI (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

PET

Exhibit 39: Bioimaging by PET (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 40: Bioimaging by PET (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

SPECT

Exhibit 41: Bioimaging by SPECT (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 42: Bioimaging by SPECT (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Other

Exhibit 43: Bioimaging by Other (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Million (Graphical Representation Included)

Exhibit 44: Bioimaging by Other (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Europe

Exhibit 45: Bioimaging (2005-2012) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Analysis by Type

Medical

Exhibit 46: Medical Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 47: Medical Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Molecular

Exhibit 48: Molecular Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 49: Molecular Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Analysis by Application

Diagnostic

Exhibit 50: Bioimaging in Diagnostics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 51: Bioimaging in Diagnostics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Research and Development

Exhibit 52: Bioimaging in Research and Development (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 53: Bioimaging in Research and Development (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Analysis by Modalities

Ultrasound

Exhibit 54: Bioimaging by Ultrasound (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 55: Bioimaging by Ultrasound (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

CT

Exhibit 56: Bioimaging by CT (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 57: Bioimaging by CT (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

MRI

Exhibit 58: Bioimaging by MRI (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 59: Bioimaging by MRI (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

PET

Exhibit 60: Bioimaging by PET (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 61: Bioimaging by PET (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

SPECT

Exhibit 62: Bioimaging by SPECT (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 63: Bioimaging by SPECT (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Other

Exhibit 64: Bioimaging by Other (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 65: Bioimaging by Other (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Japan

Exhibit 66: Bioimaging (2005-2012) -Japanese Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Asia-Pacific

Exhibit 67: Bioimaging (2005-2012) - ^Asia-Pacific Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Analysis by Type

Medical

Exhibit 68: Medical Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 69: Medical Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Molecular

Exhibit 70: Molecular Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 71: Molecular Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Analysis by Application

Diagnostic

Exhibit 72: Bioimaging in Diagnostics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 73: Bioimaging in Diagnostics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Research and Development

Exhibit 74: Bioimaging in Research and Development (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 75: Bioimaging in Research and Development (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Analysis by Modalities

Ultrasound

Exhibit 76: Bioimaging by Ultrasound (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 77: Bioimaging by Ultrasound (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

CT

Exhibit 78: Bioimaging by CT (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 79: Bioimaging by CT (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

MRI

Exhibit 80: Bioimaging by MRI (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 81: Bioimaging by MRI (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

PET

Exhibit 82: Bioimaging by PET (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 83: Bioimaging by PET (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

SPECT

Exhibit 84: Bioimaging by SPECT (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 85: Bioimaging by SPECT (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Other

Exhibit 86: Bioimaging by Other (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 87: Bioimaging by Other (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific

Latin America

Exhibit 88: Bioimaging (2005-2012) - Latin America Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

Analysis by Type

Medical

Exhibit 89: Medical Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 90: Medical Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Molecular

Exhibit 91: Molecular Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 92: Molecular Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Analysis by Application

Diagnostic

Exhibit 93: Bioimaging in Diagnostics (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 94: Bioimaging in Diagnostics (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Research and Development

Exhibit 95: Bioimaging in Research and Development (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 96: Bioimaging in Research and Development (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Analysis by Modalities

Ultrasound

Exhibit 97: Bioimaging by Ultrasound (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 98: Bioimaging by Ultrasound (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

CT

Exhibit 99: Bioimaging by CT (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 100: Bioimaging by CT (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

MRI

Exhibit 101: Bioimaging by MRI (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 102: Bioimaging by MRI (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

PET

Exhibit 103: Bioimaging by PET (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 104: Bioimaging by PET (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

SPECT

Exhibit 105: Bioimaging by SPECT (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 106: Bioimaging by SPECT (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Other

Exhibit 107: Bioimaging by Other (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 108: Bioimaging by Other (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America

Rest of World

Exhibit 109: Bioimaging (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

III. PRODUCT TECHNOLOGY/RESEARCH

Introduction

Imaging Techniques

Imaging Techniques in Drug Development

Digital Imaging

Digital Image Processing

1. Image

2. Digital Images

3. Digital Image Processing Systems

4. Analog vs. Digital Images

5. Converting from Analog Image to Digital Image

6. Color and Grayscale Images

7. Digital Image Processing (DIP) System

8. Digital Image Processing Steps

Principles of Diagnostic Imaging Tools

A. Magnetic Resonance Imaging

B. Single Photon Emission Computed Tomography

C. Computed Tomography

The Present Day Imaging Technology

Fluoroscopy Techniques

Structure and Set Up of Initial Fluoroscope Design

X-Ray Image Intensifiers: An Apparatus to View Images under Normal Light

Flat-Panel Detectors: A Replacement for Image Intensifiers

Bioimaging Growth Trends - Global Markets

Exhibit 110: Global Market for Bioimaging: Geographic Regions (Japan, Asia-Pacific, Rest of World, Europe, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Segmentation of Bioimaging

Segmentation by Type

Growth Trends - Global Market for Bioimaging by Type

Exhibit 111: Global Market for Bioimaging by Type (Molecular and Medical) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Medical

Growth Trends - Global Market for Medical Bioimaging

Exhibit 112: Global Market for Medical Bioimaging: Geographic Regions (Asia-Pacific, Europe, Latin America, Japan, Rest of World and North America) Ranked by projected CAGR for 2005 through 2012 (Graphical Representation Included)

Medical Imaging

Medical Imaging Fluoroscopy - Advantages

Molecular

Growth Trends - Global Market for Molecular Bioimaging

Exhibit 113: Global Market for Molecular Bioimaging: Geographic Regions (Rest of World, Japan, Asia-Pacific, Europe, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Molecular Imaging

Enhancements in Cancer through Molecular Imaging

The Functionality of Operational Molecular Imaging in Cancer

Role of PET in Molecular Imaging in Relation to Cancer

Molecular Imaging Usage in Improvising Cancer Therapeutics

Application of Molecular Imaging in Chemotherapy

Molecular Imaging in Neurology

PET based Molecular Imaging for Neurological Ailments

Prospects for Molecular Neuroimaging

Segmentation by Application

Growth Trends - Global Market for Bioimaging by Application

Exhibit 114: Global Market for Bioimaging by Application (Research and Development and Diagnostic) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Diagnostic

Growth Trends - Global Market for Diagnostic Bioimaging

Exhibit 115: Global Market for Bioimaging in Diagnostics: Geographic Regions (Asia- Pacific, Europe, Rest of World, Japan, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Molecular Imaging of the Lungs

Molecular Imaging of Musculoskeletal Diseases

Molecular Imaging of the Kidneys with PET

Molecular Imaging of Antiangiogenic Agents

Craniofacial Scanning

Chest Scanning

Cardiac Scanning

Abdominal Scanning

Pelvis Scanning

Research and Development

Growth Trends - Global Market for Bioimaging by Other Methods

Exhibit 116: Global Market for Bioimaging in Research and Development: Geographic Regions (Japan, North America, Rest of World, Asia-Pacific, Europe, and Latin America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Functional Imaging in Drug Discovery and Development

Role of Imaging Biomarkers in the Discovery and Development of Cancer Drugs

Advantages of Biomarkers

Reporter Mice and Drug Discovery and Development

The Potential of High-Content High-Throughput Microscopy in Drug Discovery

Noninvasive Imaging of Melanoma with Reflectance Mode Confocal Scanning Laser Microscopy

Dynamic Imaging of Chemokine-Dependent CD8+ T cell Help for CD8+ T cell Responses

Functional Genomics and Radioisotope-Based Imaging Procedures

Imaging and Oncologic Drug Development

The Role of Bioimaging in Drug Discovery

Clinical Biomarkers in Drug Discovery and Development

Using Imaging Biomarkers to Accelerate Drug Development and Clinical Trials

Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics

Development and Use of Biomarkers in Oncology Drug Development

Biomedical /Medico Related Benefits in R&D via Biomarkers

Right Parietal Dysfunction in Children with Attention Deficit Hyperactivity Disorder, Combined Type A Functional MRI Study

Molecular, Cellular and Functional Imaging of Atherothrombosis

Segmentation by Modalities

Growth Trends - Global Market for Bioimaging by Modalities

Exhibit 117: Global Market for Bioimaging by Modalities (PET, SPECT, CT, MRI, Other and Ultrasound) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Ultrasound

Growth Trends - Global Market for Bioimaging by Ultrasound

Exhibit 118: Global Market for Bioimaging by Ultrasound: Geographic Regions (Asia-Pacific, Latin America, Europe, Japan, Rest of World and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Ultrasound - Types

3D Ultrasound

Ultrasonography

Modes of Sonography

Doppler Sonography

Strengths of Sonography

Medical Ultrasonography

Healing Sound: The Use of Ultrasound in Drug Delivery and Other Therapeutic Applications

Application of Intravascular Ultrasound in Anti-Atherosclerotic Drug Development

High Intensity Focused Ultrasound (HIFU) - Technology for Treatment of Cancer

CT

Growth Trends - Global Market for Bioimaging by CT

Exhibit 119: Global Market for Bioimaging by CT: Geographic Regions (Asia-Pacific, Japan, Europe, Rest of World, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Computed Tomography

Tomosynthesis

Types of Acquisition

i. Scout/Pilot/Tomogram

ii. Axial

iii. Cine

iv. Helical

v. DRR

vi. Generations

vii. Electron Beam CT

viii. Helical or Spiral CT

xi. Multislice CT

x. Dual Source CT

xi. 256 Slice CT

xii. Inverse Geometry CT

xiii. 3D Rendering Techniques

MRI

Growth Trends - Global Market for Bioimaging by MRI

Exhibit 120: Global Market for Bioimaging by MRI: Geographic Regions (Japan, Asia-Pacific, Europe, Latin America, Rest of World and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Magnetic Resonance Imaging (MRI): The Latest Advancements in Imaging Technology

i. Diffusion Magnetic Resonance Imaging

ii. Magnetic Resonance Angiography

iii. Magnetic Resonance Spectroscopy

iv. Functional Magnetic Resonance Imaging

Magnetic Resonance Imaging and its Advantage over Conventional X-Ray and CT Scans

Primary Aim of fMRI Data Analysis

The Available Varieties of Sophisticated MRI Scans

Diffusion Magnetic Resonance Imaging: An Effective way of Measuring Water Molecules in Biological Tissues

Magnetic Resonance Angiography: A Method for Analyzing Arteries

Magnetic Resonance Spectroscopy: A Combination of NMR Spectroscopy and Spatially Addressable MRI

Functional Magnetic Resonance Imaging: An Indicator of Brain’s Neural Activity

Interventional MRI

Radiation Therapy Simulation: An Effective Method for Location of Tumors

Current Density Imaging: Works on Principle of Generation of Magnetic Field

Magnetic Resonance Guided Focused Ultrasound

Multinuclear Imaging to aid Functional Imaging

Multi-Mode Imaging System and its Application to Achieve Thermal Ablation

Role of fMRI in Optimizing CNS Drug Development

Nuclear Medicine Imaging: A Novel Means of Drug Discovery in Gene Therapy

Diagnostic Testing

Types of Radionuclides

Imaging Equipment

Analysis

Radionuclide Imaging in Drug Development

Receptor Imaging in Oncology by Means of Nuclear Medicine

Nuclear Medicine Studies of the Prostate, Testes and Bladder

In Vivo Imaging of Oligonucleotides with Nuclear Tomography

Molecular Imaging in Evaluation of In Vivo Behavior of Drugs

Nuclear Imaging Methods for Non-Invasive Drug Monitoring

Biomedical Imaging in Pharmacology with Nuclear Medical Imaging Methodologies

Nuclear Medicine Radiopharmaceuticals

PET

Growth Trends - Global Market for Bioimaging by PET

Exhibit 121: Global Market for Bioimaging by PET: Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe, North America and Latin America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Positron Emission Tomography

Application of PET Scanning in Medicine and Research

Applications in Drug Discovery and Drug Development

Role of PET in Pharmacokinetic Analysis

Pharmacokinetic Imaging: A Non-invasive Method for Determining Drug Distribution and Action

Positron Emission Tomography Implications in the Advancement of Molecular aimed Cancer Curatives

Functional PET Imaging in Anti-Cancer Drug Development

Using PET to Facilitate CNS Drug Development

Pharmacokinetic Considerations in the PET and SPECT Evaluation of CNS Receptors

PET for In Vivo Pharmacokinetic and Pharmacodynamic Measurements

Psychotropic Drug Development using PET

PET and SPECT Imaging of the Opioid System: Receptors, Radioligands

PET in Treatment of Movement Disorders

Application of PET Scans in the Field of Oncology

PET Neuroimaging Scan to Analyze Activities of the Human Brain

Application of PET Scan in Neuropsychology and Cognitive Neuroscience

Application of PET Imaging in Treatment of Pediatric Hodgkin's Lymphoma

Potential Application of PET/CT Imaging in the Treatment of Lung Cancer

Radio Isotope Compounds Utilized in PET Scanning

SPECT

Growth Trends - Global Market for Bioimaging by SPECT

Exhibit 122: Global Market for Bioimaging by SPECT: Geographic Regions (Asia-Pacific, Europe, Japan, Rest of World, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Applications of Single Photon Emission Computed Tomography (SPECT)

Other

Growth Trends - Global Market for Bioimaging by Other

Exhibit 123: Global Market for Bioimaging by Other: Geographic Regions (Japan, Rest of World, Asia-Pacific, Europe, Latin America and North America) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)

Projection Radiography

Mammography

Dental Radiography

Digital Radiography

Other Detection Devices

Geiger Counter

Scintillators

Fluoroscopy

Energy Dispersive X-Ray Spectroscopy

Electron Microscopes for Bioimaging

a. Scanning Electron Microscope (SEM)

b. Transmission Electron Microscope (TEM)

c. Scanning Transmission Electron Microscopy (STEM)

d. Reflection Electron Microscope (REM)

Bioimaging Procedures being used or Developed for Generating 3D Images

a. Diffuse Optical Tomography (DOT) or Diffuse Optical Imaging (DOI)

b. Elastography

c. Electrical Impedance Tomography

d. Optoacoustic Imaging

e. Ophthalmology

A-Scan Ultrasound Biometry

B-Scan Ultrasonography

C-Scan Ultrasonography

f. Corneal Topography

g. Optical Coherence Tomography

h. Scanning Laser Ophthalmoscopy

Types of Tomography

Based on Movement

i. Linear Tomography

ii. Poly Tomography

iii. Zonography

iv. Orthopantomography

v. Computed Tomography

vi. Tomosynthesis

vii. Electron Beam CT

viii. Helical or Spiral CT

ix. Multislice CT

x. 256 Slice CT

xii. Inverse Geometry CT

xiii. 3D Rendering Techniques

Based on Principle of Working

a. Confocal Laser Scanning Microscopy

b. Cryo-Electron Tomography

c. Magnetic Induction Tomography

d. Process Tomography

e. Photoacoustic Tomography

f. Single Photon Emission Computed Tomography

g. X-ray Tomography

h. Positron Emission Tomography

i. Optical Coherence Tomography

Single Point Optical Coherence Tomography

Parallel Optical Coherence Tomography

Fluorescence Lifetime Imaging

Gallium Imaging

Optoacoustic Imaging

Photoacoustic Imaging

Diffusion-Weighted Imaging

Bioluminescence Imaging

Calcium Imaging

Diagnostic Imaging Agents

A. Reagents

B. Contrast agents

Exhibit 124: Imaging Agents (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for the United States, Japan, Europe and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 125: Imaging Agents (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for the United States, Japan, Europe and Rest of World (Graphical Representation Included)

Exhibit 126: Therapeutic and Diagnostic Imaging Antibodies (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

/DL>

Neuroimaging

Basics of Brain Imaging

Computed Axial Tomography

Magnetic Resonance Imaging

Working of MRI

Functional Magnetic Resonance Imaging

fMRI Technique: Mixture of Technical and Medical Fields

Advantages of fMRI

Other Techniques

Contrast MR

Arterial Spin Labeling

Magnetic Resonance Spectroscopic Imaging

Diffusion Tensor Imaging

Positron Emission Tomography

Molecular Neuroimaging

Latest Technologies in Neuroimaging

Radioactivity and Brain Imaging

Multimodal Neuroimaging

Functional Brain Imaging

Neuroimaging for Neuropsychiatry

Diagnosing and Treating Neuroendocrine Tumors

Neuropharmacology and Drug Development

Spontaneous Fluctuations in Brain Activity Observed with Functional Magnetic Resonance Imaging

Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT

Treatment for Behavioural Disorders in Neurodegenerative Diseases: Drug Development Strategies

Computational Bioimaging

Bioimaging Software

A. Mimics3D Application Deliverables

B. Analysis of Functional Neuro Images

C. Neuro Imaging Application

D. SAS (Ictal-Interictal SPECT Assay by SPM)

Neuroimaging Software

Digital Signal Processing (DSP)

Optimization and Advantages of FPGA

Standardized Digital Photography in Medicine

Consistent Photo Documentation for Clinical Trials

Biosoftware Dermoscope

Grid-based Computer-Aided Detection System (Grid CAD)

Computational Genomics Research - Advantages

Intervention Magnetic Character Imaging

Radiation Cure Reproduction

Current Density Imaging

High Powered Magnetic Character Concentrated Ultrasound Function

1. High Intensity Focused Ultrasound

2. Functionality of High Intensity Focused Ultrasound

Multinucleate Imaging

Analytical Magnetic Character Imaging Techniques

Interpretation and Interpolation of Data using Imaging

Hurdles Encountered During Imaging

IV. MARKET DYNAMICS

1. Market Overview

Bioimaging - A Prominent Advancement in the Field of Biomedical Research

Medical Imaging and its Prospective Role in Pharmaceutical Clinical Trials

Whole Body Imaging

2. Global Market Analysis

Exhibit 127: Bioimaging (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Billion (Graphical Representation Included)

Exhibit 128: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World

Market Analysis by Segmentation

Analysis by Type

Exhibit 129: Bioimaging (2005-2012)-Global Market Analysis (Current and Future) by Type for Medical and Molecular in US$ Billion (Graphical Representation Included)

Exhibit 130: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 131: Bioimaging (2005-2012)-Global Market Analysis (Current and Future) by Application for Diagnostics and Research and Development in US$ Billion (Graphical Representation Included)

Exhibit 132: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 133: Bioimaging (2005-2012)-Global Market Analysis (Current and Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Billion (Graphical Representation Included)

Exhibit 134: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

Exhibit 135: Radiography Systems (2005-2012)-Global Market Analysis (Current and Future) in US$ Billion (Graphical Representation Included)

3. Market Trends

Focus of Bioimaging

Future of Bioimaging

Bioimaging - Present and Future

Less Invasive Mammography

Looking into the Brain

Pocket - size Ultrasound

4. Major Global Companies In Bioimaging Industry

Advanced Research Technologies, Inc. (Canada)

Analogic Corporation (USA)

Bayer Schering Pharma AG (Germany)

Bio-Imaging Technologies, Inc.(USA)

Bracco Group ( I t a l y )

Carestream Health, Inc. (USA)

Carl Zeiss SMT AG ( G e r m a n y )

CellPoint LLC. (USA)

Del Global Technologies Corporation (USA)

Draxis Health, Inc.(Canada)

Esaote SpA (Italy)

FEI Company (USA)

FOCUS GmbH(Germany)

FONAR Corporation (USA)

Gamma Medica - Ideas, In. (USA)

GE Healthcare (UK)

Genetix Ltd.(UK)

Guerbet SA (France)

Hitachi Medical Corporation (Japan)

Hologic, Inc. (USA)

IMIX ADR Ltd. (Finland)

InfiMed, Inc. (USA)

IRIS International, Inc.(USA)

JEOL, Ltd. (Japan)

Kereos, Inc.(USA)

Koninklijke Philips Electronics NV (The Netherlands)

Lantheus Medical Imaging (USA)

Mallinckrodt, Inc. (USA)

Medison Co. Lt.d. (South Korea)

Mindray Bio-Medical Electronics Co., Lt. (China)

Neusoft Group Ltd. (China)

Polartechnics Limited (Australia)

Shimadzu Corporation (Japan)

Siemens AG (Germany)

SonoSite, Inc. (USA)

Swissray Medical AG (Switzerland)

The Samon Imaging Systems (India)

VisEn Medical, Inc. (USA)

VisualSonics, Inc. (Canada)

VMI - Sistemas Médicos (Brazil)

5. Major Activities in Bioimaging Industry

Jubilant Completes Acquisition of Draxis Health

Mindray Acquires Datascope’s Patient Monitoring Business

GE Healthcare Acquires Whatman…

Agilent Acquires Till Photonics…

Genetix Obtains US Patent for Robotic Platform Imaging Technologies and ClonePix FL…

Bayer Acquires Radiolabeling Technology of PET Tracers…

Image Diagnost Acquired by GE Healthcare…

Tentative FDA Approval for Generic Myocardial Perfusion Imaging Kit of Covidien…

BK Medical and Advanced Medical Diagnostics in Collaboration Agreement for HistoScanning™ Technology for Prostate…

Obstetrician licenses Patented Ultrasound Diagnostic Protocol to GE Healthcare…

ImaRx Therapeutics and Philips in Research Collaboration…

TechniScan and Esaote Group in Partnership Agreement…

Gamma Medica-Ideas in Breast Cancer Research Collaboration with Mayo…

Bracco Acquires E-Z-EM for $241 million in Cash…

Envisioneering and Varian in combined effort to treat Prostate Cancer with Highly Targeted Radiation Therapy….

GE Healthcare Buys Dynamic Imaging LLC

Carl Zeiss Purchases Entire Stake in Wolf & Beck…

Carl Zeiss’ Imaging and Analysis Instruments to be used by FAS of Harvard University with …

Eckert & Ziegler Purchases MC Pharma based in Rhineland…

GE Healthcare Signs Agreement with Novation

Med Discovery Collaborates with DRAXIMAGE...

ART and Stanford Join Hands to Improve Diagnosis and Monitor Treatment for Breast Cancer

SonoSite Acquires Catheter Guidance Technology…

GlaxoSmithKline, Imperial College London, and The Medical Research Council Introduce CIC -

The Largest Center In Europe for Clinical Research

Boston Life Sciences Inc. Renamed as Alseres Pharmaceuticals Inc.

Varian Medical Systems Buys Bio-Imaging Research

Esaote Group Purchases the Entire Stake in Kontron Medical…

Genetix Acquires Applied Imaging Corporation. Acquisition Expects to Improve Range and Scope of the Drug Discovery Process

ART Signs Distribution Agreement with GE Healthcare for eXplore Optix

Analogic Corporation Joins Hands with CAS Medical Systems to Commercialize its LIFEGARD Family of Non-invasive Patient Monitors

Varian Medical Systems Receives Regulatory Clearance from Japanese Government for Novel 3-D Imaging with On-Board Imager Device for Image-Guided Radiotherapy

VisEn Signs Agreement with Merck to Create New Molecular Imaging Agents for Exclusive Cardiovascular Diseases

Cytogen Commences the Phase 1 Trial for Radiolabeled Antibody for Therapeutic Application in Hormone-Refractory Prostate Cancer…

Varian Medical Systems Acquires ACCEL Instruments GmbH

New Imaging Compounds to be Developed to Detect Neurodegenerative Diseases

MIR to provide Cancer Pharmacology Preclinical Services to Emiliem…

IPL Adopts New Corporate Identity…

Gamma Medica-Ideas Buys Advanced Molecular Imaging

Schering AG to Work with Stanford University in the Field of Molecular Imaging

ESAOTE Collaborates with EIZO for Developing High-Techn Imaging…

Iris Diagnostics Signs Five-Year Agreement with LabCorp for Automated Urine Microscopy

U.S. FDA Grants Hologic Clearance to Use Hip Structure Analysis in DXA Systems

MIR and VWR in Partnership Agreement to Provide Expanded Development Services….

Schering AG Signs Agreement with Avid Radiopharmaceuticals to Develop New Agents for the Early Diagnosis of Alzheimer’s disease

VisualSonics and Bracco Sign Collaboration Agreement for Developing and Manufacturing MicroMarker™ Contrast Agents, Kits and Protocols…

Hologic to Work Together with the Johns Hopkins University on Hip Structure Analysis

Schering Forms Strategic Alliance with Philips for Optical Imaging to Treat Breast Cancer

Schering AG to Work Together with Siemens Medical Solutions to Explore Novel Computer Tomography Technology

Macrocyclics Signs Research Collaboration Agreement with MDS Nordion

MIR and Gamma Medica in Strategic Alliance…

6. Major Product Innovations/Launches in Bioimaging Industry

CytoGenetix FISH Reagents and Kits Launched by Genetix

FEI Launches Titan Krios™ TEM for Structural Biology

JEOL Introduces Dual Beam Milling/Imaging System JIB-4500

Philips Launches Latest Fetal-Maternal Monitors with Touch Screen Display

Philips Launches Latest Computed Tomography (CT) Scan System…

Innovative Emergency Medicine Tool for Point-Of-Care Visualization Launched by SonoSite

SonoSite Launches Advanced Ultrasound System

SonoSite Launches Innovative Visualization Tool for Anesthesiologists

Siemens Launches Latest Low-cost 1.5 T High-field MRI system

MEDRAD® Announces eCoil™ for Use with Siemens, Philips Scanners

Carl Zeiss SMT Unveils CENTRA™ 100, the Novel 100 kV TEM

MEDRAD Unveils New Pressure-Rated Disposable for CT Power Injection

FEI Launches MicroValidator(TM) Software for Application in SEMs and EDS

MEDRAD Unveils New Extravasation Detector Technology

Hologic Launches Two New Suros Biopsy Markers to Identify Multiple Biopsy Sites in the Same Breast

Biosound Esaote Releases the XVision Platform

FEI Launches Novel Phenom(TM) for High-Resolution Imaging….

New High Resolution CT Subsystem Ready for Commercial Launch

New Varian Linear Accelerators with On-Board Imagers Developed to Provide Image-Guided Radiation Therapy to Treat Cancer

FEI Unveils the New Nova NanoSEM™ 30 Series

VisEn Introduces New Products into its Existing Probe Portfolio to Enable Research in Specific Diseases and Drug Development

Carl Zeiss SMT Introduces ORION™ Helium Ion Microscope in the Market

Expanded SonoMB™ Technology from SonoSite

Genetix Introduces New Cell-Based Assay Platform

Commercial Launch of eXplore Optix MX2 that Offers a New Standard for Performance and Flexibility

GE Healthcare Develops New Laptop-Size Ultrasound for Women’s Healthcare

B-K Medical Introduces New Prostate and Transvaginal Transducer with the Finest Image Quality

Esaote Launches the Novel 3.0 Software Package for Mylanta Gold range

New Compact Ultrasound System with High Performance Image Quality from GE Healthcare

B-K Medical Introduces the Only Prostate Transducer to Combine Two Ultrasound Techniques in One to Give Simultaneous Biplane and Endfire Imaging

Esaote Launches the Novel MyLabTM60, an Advanced Ultrasound Scanner for Cardiovascular and General Imaging…

Carl Zeiss Launches AxioVision Software Version 4.6, Incorporating Novel Features in the Digital Microscopic Offerings…

New Transmission Electron Microscope Ready for Commercialization

Gamma Medica-Ideas Launches New Revolutionary CZT-based SPECT Pre-Clinical Imaging Camera

JEOL Launches New Field Emission Transmission Electron Microscope

VisEn Medical Launches Nanosparks™ - the New Range of Optical Imaging Probes

New Cardiovascular Features Added to VisualSonics’ Vevo 770 Micro-Ultrasound System

JEOL Introduces New Thermal Field Emission Scanning Electron Microscope

Hologic Launches New Tomographic 3-D Image Reconstruction for DXA

Gamma Medica-Ideas New Revolutionary Biomolex® 700 Imager

7. Regional Market Analysis

A. NORTH AMERICA

Exhibit 136: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 137: List of Major Companies In North America

Analysis by Geographic Region

Exhibit 138: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the United States and Canada in US$ Billion (Graphical Representation Included)

Exhibit 139: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the United States and Canada (Graphical Representation Included)

Analysis by Type

Exhibit 140: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Billion (Graphical Representation Included)

Exhibit 141: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 142: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Billion (Graphical Representation Included)

Exhibit 143: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 144: Bioimaging (2005-2012) - North American Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Billion (Graphical Representation Included)

Exhibit 145: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

A1. United States

Analysis by Type

Exhibit 146: Bioimaging (2005-2012) - United States Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Billion (Graphical Representation Included)

Exhibit 147: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United States Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 148: Bioimaging (2005-2012) - United States Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Billion (Graphical Representation Included)

Exhibit 149: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United States Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 150: Bioimaging (2005-2012) - United States Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Billion (Graphical Representation Included)

Exhibit 151: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United States Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

A2. Canada

Analysis by Type

Exhibit 152: Bioimaging (2005-2012) - Canadian Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 153: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 154: Bioimaging (2005-2012) - Canadian Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 155: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 156: Bioimaging (2005-2012) - Canadian Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 157: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

B. EUROPE

Exhibit 158: Bioimaging (2005-2012) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 159: List of Major Companies In Europe

Analysis by Geographic Region

Exhibit 160: Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)

Exhibit 161: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)

Analysis by Type

Exhibit 162: Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 163: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 164: Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 165: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 166: Bioimaging (2005-2012) - European Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 167: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

Exhibit 168: Digital Radiography (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

B1. Germany

Analysis by Type

Exhibit 169: Bioimaging (2005-2012) - German Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 170: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 171: Bioimaging (2005-2012) - German Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 172: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 173: Bioimaging (2005-2012) - German Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 174: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

B2. United Kingdom

Analysis by Type

Exhibit 175: Bioimaging (2005-2012) - United Kingdom Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 176: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United Kingdom Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 177: Bioimaging (2005-2012) - United Kingdom Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 178: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United Kingdom Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 179: Bioimaging (2005-2012) - United Kingdom Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 180: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of the United Kingdom Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

B3. France

Analysis by Type

Exhibit 181: Bioimaging (2005-2012) - French Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 182: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 183: Bioimaging (2005-2012) - French Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 184: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 185: Bioimaging (2005-2012) - French Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 186: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

B4. Italy

Analysis by Type

Exhibit 187: Bioimaging (2005-2012) - Italian Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 188: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Italian Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 189: Bioimaging (2005-2012) - Italian Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 190: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Italian Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 191: Bioimaging (2005-2012) - Italian Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 192: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Italian Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

B5. Rest of Europe

Analysis by Type

Exhibit 193: Bioimaging (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 194: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 195: Bioimaging (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 196: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 197: Bioimaging (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 198: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

C. JAPAN

Exhibit 199: Bioimaging (2005-2012) - Japanese Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 200: List of Major Companies In Japan

Analysis by Type

Exhibit 201: Bioimaging (2005-2012) - Japanese Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 202: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 203: Bioimaging (2005-2012) - Japanese Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 204: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 205: Bioimaging (2005-2012) - Japanese Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 206: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

D. ASIA-PACIFIC

Exhibit 207: Bioimaging (2005-2012) - ^Asia-Pacific Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 208: List of Major Companies In Asia-Pacific

Analysis by Geographic Region

Exhibit 209: Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)

Exhibit 210: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Australia, China, India and Rest of Asia-Pacific (Graphical Representation Included)

Analysis by Type

Exhibit 211: Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 212: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 213: Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 214: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 215: Bioimaging (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 216: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

Exhibit 217: Digital and Computed Radiography (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)

D1. Australia

Analysis by Type

Exhibit 218: Bioimaging (2005-2012) - Australian Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 219: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 220: Bioimaging (2005-2012) - Australian Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 221: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 222: Bioimaging (2005-2012) - Australian Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 223: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

D2. China

Analysis by Type

Exhibit 224: Bioimaging (2005-2012) - Chinese Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 225: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 226: Bioimaging (2005-2012) - Chinese Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 227: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 228: Bioimaging (2005-2012) - Chinese Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 229: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

D3. India

Analysis by Type

Exhibit 230: Bioimaging (2005-2012) - Indian Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 231: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 232: Bioimaging (2005-2012) - Indian Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 233: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 234: Bioimaging (2005-2012) - Indian Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 235: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

D4. Rest of Asia-Pacific

Analysis by Type

Exhibit 236: Bioimaging (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 237: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 238: Bioimaging (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 239: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 240: Bioimaging (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 241: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

E. LATIN AMERICA

Exhibit 242: Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Exhibit 243: List of Major Companies In Latin America

Analysis by Geographic Region

Exhibit 244: Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Geographic Region for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)

Exhibit 245: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)

Analysis by Type

Exhibit 246: Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 247: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 248: Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 249: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 250: Bioimaging (2005-2012) - Latin American Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 251: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Latin American Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

E2. Brazil

Analysis by Type

Exhibit 252: Bioimaging (2005-2012) - Brazilian Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 253: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 254: Bioimaging (2005-2012) - Brazilian Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 255: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 256: Bioimaging (2005-2012) - Brazilian Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 257: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Brazilian Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

E3. Mexico

Analysis by Type

Exhibit 258: Bioimaging (2005-2012) - Mexican Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 259: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Mexican Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 260: Bioimaging (2005-2012) - Mexican Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 261: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Mexican Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 262: Bioimaging (2005-2012) - Mexican Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 263: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Mexican Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

E4. Rest of Latin America

Analysis by Type

Exhibit 264: Bioimaging (2005-2012) - Rest of Latin America Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 265: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Latin America Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 266: Bioimaging (2005-2012) - Rest of Latin America Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 267: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Latin America Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 268: Bioimaging (2005-2012) - Rest of Latin America Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 269: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of Latin America Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

F. REST OF WORLD

Exhibit 270: Bioimaging (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)

Analysis by Type

Exhibit 271: Bioimaging (2005-2012) - Rest of World Market Analysis (Current & Future) by Type for Medical and Molecular in US$ Million (Graphical Representation Included)

Exhibit 272: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Type for Medical and Molecular (Graphical Representation Included)

Analysis by Application

Exhibit 273: Bioimaging (2005-2012) - Rest of World Market Analysis (Current & Future) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)

Exhibit 274: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Application for Diagnostics and Research and Development (Graphical Representation Included)

Analysis by Modalities

Exhibit 275: Bioimaging (2005-2012) - Rest of World Market Analysis (Current & Future) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)

Exhibit 276: Bioimaging (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)

8. Bioimaging - Industry Outlook

V. CORPORATE DIRECTORY

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.